Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-020578

Chief Operations Officer sold 7,000 shares at $17.41 ($121,870)

  • Chief Operations Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Newell Joe · Chief Operations Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Exercise or conversion : show line 1 in the form +3,500 $12.15 $42,525 145,219 D
2021-03-15 Sale : show line 2 in the form −7,000 $17.41 $121,870 138,219 D
Open-market sales · 7,000 sh · avg $17.41 · $121,870

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-15 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −2,791 43,250 D
2021-03-15 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) −709 12,750 D
Loading xslF345X03/doc4.xml…